Chris Freeman Insider Trades & Stock Holdings

Chief Commercial Officer · Guardant Health, Inc. · Latest filing Jun 15, 2026

Chris Freeman, Chief Commercial Officer at Guardant Health, Inc. has 2 Form 4 trades on file since Jun 15, 2026. Latest filing: disposed of 594 shares of $GH on Jun 15, 2026 at $129.82.

Trades on file: 2
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 15, 2026

All insider trades by Chris Freeman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$GH	Sell (Tax withholding)	594	$129.82	$77.11K			-0.8%	+25.5%		Chief Commercial Officer		—
Jun 15, 2026	$GH	Buy (Option exercise)	1.40K	$0	—			-0.8%	+25.5%		Chief Commercial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Chris Freeman traded

Frequently asked questions

What was Chris Freeman's latest insider trade?

disposed of 594 shares of $GH on Jun 15, 2026 at $129.82.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text